Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05110742 |
|---|---|
| Brief Title: | Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances |
| First Submitted : | September 28, 2021 |
| First Submitted that Met QC Criteria : | October 26, 2021 |
| First Posted : | November 8, 2021 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |